secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2021-09-23T23:59:59+00:00
Accession:  0001654954-21-010321
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma files 8-K regarding ESMO 2021 presentation; no financial results disclosed
--------------------------------------------------------------------------------

- Dr. Jeffrey Miller presented on GT Biopharma's drug candidates at ESMO Congress 2021.
- Updated corporate presentation posted to website as of Sept 20, 2021.
- No specific clinical data or financial figures included in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000165495421010321/0001654954-21-010321-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000165495421010321/gtbp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-21-010321

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer